Online citations, reference lists, and bibliographies.
← Back to Search

Paradoxical Relationship Between Chromosomal Instability And Survival Outcome In Cancer.

N. Birkbak, A. Eklund, Qiyuan Li, S. E. McClelland, D. Endesfelder, P. Tan, I. Tan, A. Richardson, Z. Szallasi, C. Swanton
Published 2011 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Chromosomal instability (CIN) is associated with poor prognosis in human cancer. However, in certain animal tumor models elevated CIN negatively impacts upon organism fitness, and is poorly tolerated by cancer cells. To better understand this seemingly contradictory relationship between CIN and cancer cell biological fitness and its relationship with clinical outcome, we applied the CIN70 expression signature, which correlates with DNA-based measures of structural chromosomal complexity and numerical CIN in vivo, to gene expression profiles of 2,125 breast tumors from 13 published cohorts. Tumors with extreme CIN, defined as the highest quartile CIN70 score, were predominantly of the estrogen receptor negative (ER(-)), basal-like phenotype and displayed the highest chromosomal structural complexity and chromosomal numerical instability. We found that the extreme CIN/ER(-) tumors were associated with improved prognosis relative to tumors with intermediate CIN70 scores in the third quartile. We also observed this paradoxical relationship between CIN and prognosis in ovarian, gastric, and non-small cell lung cancer, with poorest outcome in tumors with intermediate, rather than extreme, CIN70 scores. These results suggest a nonmonotonic relationship between gene signature expression and HR for survival outcome, which may explain the difficulties encountered in the identification of prognostic expression signatures in ER(-) breast cancer. Furthermore, the data are consistent with the intolerance of excessive CIN in carcinomas and provide a plausible strategy to define distinct prognostic patient cohorts with ER(-) breast cancer. Inclusion of a surrogate measurement of CIN may improve cancer risk stratification and future therapeutic approaches.
This paper references
10.1186/1471-2105-9-204
Major copy proportion analysis of tumor samples using SNP arrays
Cheng Li (2007)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1073/PNAS.0506230102
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.
L. Miller (2005)
Birkbak
Cancer Res Cancer Research
(2011)
10.1158/0008-5472.CAN-06-1191
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
M. Raponi (2006)
10.1016/j.ccr.2009.10.023
Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.
Darren J Baker (2009)
10.1093/JNCI/DJJ052
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.
C. Sotiriou (2006)
10.1200/JCO.2006.05.6861
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
K. Hess (2006)
10.1073/pnas.212514799
Error catastrophe and antiviral strategy
M. Eigen (2002)
10.1158/1078-0432.CCR-07-4756
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
C. Desmedt (2008)
10.1136/gut.2007.135004
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
A. Walther (2008)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
(2011)
10.1038/nature09529
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast
Norman Pavelka (2010)
10.1038/ng1861
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
S. Carter (2006)
10.1158/0008-5472.CAN-08-4596
Copy number alterations that predict metastatic capability of human breast cancer.
Yi Zhang (2009)
10.1038/nature03799
Genes that mediate breast cancer metastasis to lung
A. Minn (2005)
10.1186/gb-2007-8-8-r157
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
A. Teschendorff (2007)
American Association for Cancer cancerres.aacrjournals.org Downloaded from Published OnlineFirst
(2011)
10.1200/JCO.2009.22.4725
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
D. Silver (2010)
Determination of oestrogenreceptor status and ERBB 2 status of breast carcinoma : a geneexpression profiling study
Y Gong (2007)
10.1186/gb-2007-8-10-r215
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
S. F. Chin (2007)
10.1038/nature04296
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
A. Bild (2006)
10.1016/S0140-6736(05)17947-1
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Y. Wang (2005)
10.1007/s10549-007-9596-6
Predicting features of breast cancer with gene expression patterns
X. Lu (2007)
10.1158/1078-0432.CCR-08-1791
Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
F. André (2009)
10.1371/journal.pgen.1000676
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
C. H. Ooi (2009)
10.1016/J.CCR.2006.10.009
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
K. Chin (2006)
10.1093/OXFORDJOURNALS.JHERED.A111354
The mutational meltdown in asexual populations.
M. Lynch (1993)
Chromosomal Instability and Cancer Survival www.aacrjournals.org Cancer Res
(2011)
10.1002/ijc.24017
The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
J. Habermann (2009)
10.1200/JCO.2006.06.3743
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
H. Dressman (2007)
10.1016/S0962-8924(99)01661-X
Genetic instability and darwinian selection in tumours.
D. Cahill (1999)
10.1073/PNAS.0401142101
Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.
G. Kops (2004)
10.1126/science.1160058
Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells
B. R. Williams (2008)
10.1016/S1470-2045(07)70042-6
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
Y. Gong (2007)
10.1126/SCIENCE.1142210
Effects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast
E. Torres (2007)
10.1038/nrc2781
Mitotic chromosomal instability and cancer: mouse modelling of the human disease
Juan-Manuel Schvartzman (2010)
Gene-expression profiles to predict distant metastasis of lymphnode-negative primary breast cancer
Y Wang (2005)
10.1186/bcr1325
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y. Pawitan (2005)
Cancer Res Cancer Research OF6 Research
(2011)
10.1073/pnas.0904343106
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
A. Janssen (2009)



This paper is referenced by
10.1093/annonc/mdy003
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
S. Venkatesan (2018)
10.1101/026302
Passenger DNA alterations reduce cancer fitness in cell culture and mouse models
C. McFarland (2015)
10.4995/thesis/10251/137036
Tumorspheres as an in vitro model for cancer stem-like cell characterization in non-small cell lung cancer. Prognostic implications
A. H. Pomares (2020)
Cancer: An Evolutionary Perspective
Jyothi Nagraj (2015)
Small Molecule Therapeutics Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS 1 Kinase Inhibitor NMSP 715
R. B. Slee (2014)
10.1371/journal.pgen.1002719
Karyotypic Determinants of Chromosome Instability in Aneuploid Budding Yeast
Jin Zhu (2012)
10.1158/0008-5472.CAN-13-0749
A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis.
Jason M. Sheltzer (2013)
10.1371/journal.pone.0056707
The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer
A. Szasz (2013)
10.1038/s41576-019-0114-6
Resolving genetic heterogeneity in cancer
S. Turajlic (2019)
10.1186/s40364-016-0058-3
A robust prognostic gene expression signature for early stage lung adenocarcinoma
M. Krzystanek (2016)
10.18632/ONCOTARGET.4879
Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy
A. Bennett (2015)
Adjuvant chemotherapy in early breast cancer The experience of the Danish Breast Cancer Cooperative Group
B. Ejlertsen (2016)
10.1016/j.canlet.2012.02.006
Centrosome amplification in tumorigenesis.
S. Anderhub (2012)
10.1371/journal.pgen.1006707
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples
S. Penner-Goeke (2017)
10.1016/j.cell.2017.01.018
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
N. McGranahan (2017)
10.1186/s13008-015-0009-7
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
Maybelline Giam (2015)
10.20892/j.issn.2095-3941.2020.0028
Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines
Natalia Vargas-Rondón (2020)
10.1101/167767
Patient-derived xenografts undergo murine-specific tumor evolution
Uri Ben-David (2017)
10.1038/ng.3967
Patient-derived xenografts undergo murine-specific tumor evolution
U. Ben-David (2017)
Le génome remanié comme oncogène des sarcomes pléomorphes
L. Delespaul (2018)
'Exploring aneuploidy: the significance of chromosomal imbalance' review series
Andrew J. Holland (2012)
An inhibitor of the mitotic kinase, MPS1, is selective towards pancreatic cancer cells
Ruchi Bansal (2014)
10.7124/BC.000059
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
A. Stepanenko (2012)
10.1038/s41467-019-13915-7
Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
Katharina von Loga (2020)
10.1038/s41556-018-0243-8
The diverse consequences of aneuploidy
Narendra Kumar Chunduri (2019)
A Genomic Study of the Evolution of Paediatric Solid Tumours
G. Cresswell (2018)
10.1158/1078-0432.CCR-19-2180
DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas
M. Weidema (2019)
On the causation and timing of mutations during cancer evolution
D. Temko (2018)
10.1158/2159-8290.CD-16-0645
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability.
Laurent Sansregret (2017)
10.1093/mutage/gey016
Geraniin selectively promotes cytostasis and apoptosis in human colorectal cancer cells by inducing catastrophic chromosomal instability
Xihan Guo (2018)
10.1038/modpathol.2015.75
Copy number analysis of ductal carcinoma in situ with and without recurrence
K. Gorringe (2015)
Integrins in Tumorigenesis and Cancer Cell Invasion
G. Högnäs (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar